Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rift Valley fever virus envelope glycoprotein Gc is an essential structural component responsible for mediating viral-host cell membrane fusion during infection. Its function depends heavily on pH-induced structural rearrangements typical of class II viral fusion proteins. Glycosylation enhances its ability to interact with specific cellular receptors involved in immune evasion or enhanced infectivity. As a key antigenic determinant targeted by neutralizing antibodies—and due to its central role in pathogenesis—it represents an important target for antiviral strategies including vaccine development or therapeutic inhibition using peptide-based approaches.
Inhibition of membrane fusion
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rift Valley fever virus envelope glycoprotein Gc (Gc).